Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study.

Background and Aims: Sudden discontinuation of buprenorphine in the treatment of opioid use disorder can increase the risk of subsequent relapse and overdose. Little is known about buprenorphine use in the perioperative period. The aim of this study was to determine the rate of buprenorphine continu...

Descripción completa

Detalles Bibliográficos
Publicado en:Addiction Vol. 118; no. 10; pp. 1953 - 1965
Autores principales: Hauck, Tanya S., Ladha, Karim S., Le Foll, Bernard, Wijeysundera, Duminda N., Kurdyak, Paul
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Oct2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=171583256&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 171583256
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Oct2023
      vid: 118
      iid: 10
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        171583256
        164362368
        171583256
        171583256
        10.1111/add.16223
        171583256
      ppf: 1953
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study.
      aug:
        au:
          Hauck, Tanya S.
          Ladha, Karim S.
          Le Foll, Bernard
          Wijeysundera, Duminda N.
          Kurdyak, Paul
        affil: Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto ON,, Canada
      sug:
        subj:
          Buprenorphine
          Perioperative Care
          Patient Discharge
          Surgery, Operative
          Human
          Substance Use Disorders
          Retrospective Design
          Prospective Studies
          Logistic Regression
          Ontario
          Adolescence
          Adult
          Odds Ratio
          Confidence Intervals
          Comparative Studies
          Analgesics, Opioid
          Descriptive Statistics
          Funding Source
          Adolescent: 13-18 years
          Adult: 19-44 years
      ab: Background and Aims: Sudden discontinuation of buprenorphine in the treatment of opioid use disorder can increase the risk of subsequent relapse and overdose. Little is known about buprenorphine use in the perioperative period. The aim of this study was to determine the rate of buprenorphine continuation after hospital discharge following surgery and factors associated with continuation. Design: A population‐based retrospective cohort study was conducted using administrative data from Ontario, Canada, between 2012 and 2018. The cohort included individuals on continuous buprenorphine prior to surgery. Logistic regression modeling was used to estimate the association of buprenorphine continuation with demographic, opioid agonist treatment, surgical and health service use factors. Setting: Administrative databases from Institute for Clinical Evaluative Sciences (ICES) were used, which capture the Ontario, Canada, population. The data sets describe physician billing, monitoring of controlled substances and hospital discharges. Participants: Adults (≥ 18 years, n = 2176) had received a buprenorphine/naloxone product continuously for at least 60 days for the treatment of opioid use disorder and subsequently underwent a surgical procedure. Measurements Continuation (versus discontinuation) of buprenorphine prescriptions in the 14 days after surgical discharge was recommended. Exposures included demographic, comorbidity, opioid agonist treatment, surgical and health service use characteristics. Findings About 176 (8.1%) of the 2176 patients discontinued buprenorphine after surgery. Inpatient surgery (versus ambulatory) was associated with reduced odds of continuation, with an unadjusted odds ratio (OR) of 0.17 [95% confidence interval (CI) = 0.12–0.25] and an adjusted OR of 0.16 (95% CI = 0.11–0.23) after accounting for age, sex, rural residence, neighborhood income quintile, Charlson comorbidity index, psychiatric hospitalizations in the past 5 years and recent dispensed supply of buprenorphine (number needed to harm of 6.6). Conclusions: In Ontario, Canada, from 2012 to 2018, most patients receiving continuous preoperative buprenorphine therapy continued buprenorphine use after surgery. Inpatient surgery was a strong predictor of discontinuation compared with ambulatory procedures.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N